baber/WOPTO huggingface dataset:
Patent NZ-552187-A (NZ)
Title: Thiophene-2-carboxamide derivatives
Inventor: ZHU BING-YAN
IPC: A61K31/381
Filed: 2005-06-20
Abstract: Disclosed are thiophene-2-carboxamide derivatives as represented by the general formula (I), or a pharmaceutically acceptable salt thereof wherein, A represents an optionally substituted benzene, a six-membered heterocycle or heteroaryl containing 1-3 nitrogen atoms or a five-membered heterocycle or heteroaryl containing 1-4 nitrogen, oxygen or sulphur atoms; R is hydrogen or alkyl; R1 is halogen, alkyl, alkenyl or alkynyl; R2 is H, alkyl, -X-OR2a, -X-SR2a, -X-COR2a, -X-CO2R2a, or -X-N(OR2a)2; W is an optionally substituted phenyl, pyridyl or piperidinyl moiety; and wherein the remaining substituents are as defined herein. Also disclosed is a composition comprising a pharmaceutically acceptable excipient and a compound as defined above. Further disclosed is the use of a therapeutically effective amount of a compound as defined above in the production of a medicament for preventing or treating a condition in a mammal characterized by undesired thrombosis (conditions such as acute coronary syndrome, myocardial infarction, unstable angina, refractory angina, occlusive coronary thrombus occurring post-thrombolytic therapy or post-coronary angioplasty, a thrombotically mediated cerebrovascular syndrome, embolic stroke, thrombotic stroke, transient ischemic attacks, venous thrombosis, deep vein thrombosis, pulmonary embolus, coagulopathy, disseminated intravascular coagulation, thrombotic thrombocytopenic purpura, thromboangiitis obliterans, thrombotic disease associated with heparin-induced thrombocytopenia, thrombotic complications associated with extracorporeal circulation, thrombotic complications associated with instrumentation such as cardiac or other intravascular catheterisation, intra-aortic balloon pump, coronary stent or cardiac valve, and conditions requiring the fitting of prosthetic devices).
Patent NZ-553329-A (NZ)
Title: Thienopyridines for treating hepatitis C
Inventor: KARP GARY MITCHELL
IPC: A61K31/4365
Filed: 2005-07-14
Abstract: Disclosed is are 3-amino-thieno[2,3-b]pyridine derivatives of formula (I) wherein X is amino, Y is an substituted oxadiazolyl or an optionally substituted 5 or 6 membered heteroaryl, R is an haloalkyl or optionally substituted alkyl, R1 is a aryl, alkyl or OCORf, where Rf is a 5 or 6 membered heterocycle, optionally substituted alkoxy and R2 is an alkyl, 5 or 6 membered heterocycle or an optionally substituted amine or a pharmaceutically acceptable salt. Also disclosed is composition comprising said derivative and the use of said derivative in the manufacture of a medicament for treating hepatitis C viral infection.
Patent NZ-554441-A (NZ)
Title: Novel aminopyridine derivatives having aurora A selective inhibitory action
Inventor: OHKUBO MITSURU
IPC: A61K33/243
Filed: 2005-10-25
Abstract: Disclosed is a compound of formula (I), or salt or solvate thereof, wherein Ra and Rb are each independently hydrogen, alkyl, or are joined to form -CH2-, Rc is a halogen atom, Rd is a halogen or methyl substituted with one to three halogen atoms, X is CH or N, and W is selected from one of the heterocycles given in the specification. Also disclosed is the use of the compound as an Aurora A selective inhibitor.
Patent NZ-560322-A (NZ)
Title: Catalyst configuration and methods for syngas production
Inventor: JIANG WEIBIN
IPC: C01B32/40
Filed: 2007-08-02
Abstract: Disclosed is a method for the partial oxidation of hydrocarbons to produce hydrogen and carbon monoxide by contacting with a mixture of a hydrocarbon-containing feed gas and an oxygen-containing gas a two stage reactor comprising a first stage reactor which comprises a catalyst composition of a first layer of a catalytically active metal dispersed on an inert carrier support and a second layer of a reduced metal catalyst consisting essentially of a transition metal supported on or in a stable inorganic metal oxide washcoated on a support, and a second stage reactor comprising a water gas shift reactor, wherein the gas stream leaving said first stage reactor is quenched with water or steam prior to entering said second stage reactor. Also disclosed is an apparatus for use in the method.
Patent NZ-561335-A (NZ)
Title: A fastener
Inventor: KINLOCH MELANIE GAY
IPC: A44B17/00
Filed: 2007-09-10
Abstract: A fastener 10 adapted to attach a visual feature 14 to a fabric, the visual feature comprising one of the group consisting of a piece of jewellery, an adornment, name tag, price tag, label, medal, and badge, the fastener 10 comprising a fastener body comprising a shank 16 having first and second ends with first and second end surfaces, respectively, wherein the first end surface is adapted to mount the visual feature to the fastener 10 and wherein the second end surface 13 of the shank 16 is substantially blunt, the shank 16 further comprising first and second portions, the first portion being located between the second portion and the first end surface of the shank 16, the first and second portions each having a periphery, wherein the width or diameter of the periphery of the first portion (d1) is less than the width or diameter of the periphery of the second portion (d2), the fastener 10 further comprising a resilient, deformable fastening means having a central aperture with a width or diameter (d3), wherein d3 < d2 and wherein the fastening means is attachable to and detachable from the shank 16.
Patent NZ-562236-A (NZ)
Title: Detection of volatile compounds as markers for Mycobacteria tuberculosis
Inventor: CHAMBERS STEPHEN T
IPC: C12M1/04
Filed: 2007-10-05
Abstract: Disclosed is a method for detecting a Mycobacterium tuberculosis or Mycobacterium bovis microorganism by analysing a gas mixture for: (i) anyone or more of methyl phenylacetate, methyl p-anisate, methyl nicotinate, and o-phenylanisole, or (ii) anyone or more of phenyl acetic acid, p-anisic acid, nicotinic acid and salicylic acid, or (iii) an ester derivative or silyl derivative of anyone or more of phenyl acetic acid, p-anisic acid, nicotinic acid and salicylic acid, where the gas mixture is obtained from a sample of breath of a patient or is obtained from a sample of the headspace gas of an in vitro culture or a biological sample.
Patent NZ-563168-A (NZ)
Title: Evaluating bacterial lethality of containerized food production
Inventor: MCCAULEY KURTIS J
IPC: C12Q1/22
Filed: 2006-04-25
Abstract: Provided is a process for determining effectiveness of timed elevated temperature thermal processing of batch- processed containerised food production operations including in-line aseptic flow-processing for aseptic containerisation production operations, for evaluating whether safe for non- refrigerated marketing, comprising (A) providing sealed test-ampoules for evaluating bacterial lethality effectiveness of elevated temperature thermal processing on food spoilage bacteria associated with batch-processed food production for determining whether safe for non-refrigerated marketing, the test-ampoules having confined therein a selected food spoilage spore-producing bacteria, in a liquid spore- culturing medium, wherein the test-ampoules are non-rigid polymeric test-ampoules constructed and arranged from a non-rigid polymeric sheet material which is capable of withstanding elevated temperature thermal processing as part of such batch food containerised production operations, while maintaining visual clarity during such thermal processing and subsequent evaluation of bacterial lethality effectiveness, (B) placing individual test-ampoules in food containers for use in containerised food production operations, The process can be used for protecting food quality.
Patent NZ-563522-A (NZ)
Title: Heterocyclic compound with immunosuppressive activity
Inventor: NISHI TAKAHIDE
IPC: A61P25/08
Filed: 2006-04-21
Abstract: Disclosed are azetidine carboxylic acid derivatives having the general formula (I) having immunosuppressive activity, where the substituents are described in the specification, particularly for treating autoimmune diseases such as rheumatic arthritis, psoriasis, atopic dermatitis, multiple sclerosis, ulcerative colitis, and Crohn's disease.
Patent NZ-576564-A (NZ)
Title: Canine lyme disease vaccine
Inventor: CALLISTER STEVEN M
IPC: A61K39/00
Filed: 2007-11-01
Abstract: A vaccine composition comprising an immunologically effective amount of organisms from a first strain of a Borrelia genospecies and an immunologically effective amount of a second strain of a Borrelia genospecies; wherein organisms of said second strain exhibit an OspA antigen, an OspB antigen, or exhibit both an OspA antigen and an OspB antigen on its cell surface; and wherein the administration of said vaccine to a canine induces significant levels of borreliacidal antibodies against B. burgdorferi 50772 (ATCC No. PTA-439).
Patent NZ-578987-A (NZ)
Title: Can with tab and panel having terraced depression
Inventor: LEBOUCHER FABRICE
IPC: B65D17/28
Filed: 2008-02-14
Abstract: A can (1) including a body provided with a panel (3), the panel being provided with a tab (6). The tab includes a front tab part (7) and a rear tab part (8) for gripping. The tab is arranged such that by gripping and levering of the rear tab part, the front tab part can be caused to engage with and to form an opening in the panel. The panel is provided with a flip panel area (17) at least beneath the rear tab part, the flip panel area forming a depression beneath the rear tab part dependent on a negative pressure difference over the panel. The flip panel area is part of a terrace structure (14-16).
Patent NZ-583008-A (NZ)
Title: Separator tank insert with weir
Inventor: CAIN STUART A
IPC: E03F5/14
Filed: 2008-07-18
Abstract: 583008 A separator tank and insert (112) are disclosed. The insert (112) comprises a weir (412) defining an intake area between the weir (412) and a side wall (106) of the tank. A round-edged orifice (502) is positioned in the intake area. In the tank the weir (412) is positioned to induce a swirling motion of the influent fluid, from intake (118), in the intake area.
Patent NZ-584336-A (NZ)
Title: Method for purifying 4-(nitrooxy)butyl(2s)-2-(6-methoxy-2-naphthyl)propanoate
Inventor: ALLEGRINI PIETRO
IPC: C07C203/04
Filed: 2009-06-18
Abstract: Disclosed is a method for purifying naproxcinod comprising the steps of: a) dissolving or dispersing a mixture containing naproxcinod in a solvent; b) cooling the solution or two phases dispersion under stirring to a temperature ranging from -20 degrees Celsius to 10 degrees Celsius; c) optionally seeding the solution with crystals of naproxcinod d) stirring, by maintaining the temperature in the range from -40 to 10 degrees Celsius; e) collecting the formed crystalline solid by maintaining the temperature under 15 degrees Celsius. Crystalline forms of naproxcinod obtained by the above method are also disclosed as are crystalline forms of naproxcinod having a melting point of 15 degrees Celsius.
Patent NZ-587217-A (NZ)
Title: Peelable composite thermoplastic sealants in packaging films
Inventor: KINIGAKIS PANAGIOTIS
IPC: B29C48/08
Filed: 2009-02-10
Abstract: A peelable seal is disclose, which comprises: a first sealing layer having a first sealing surface; a second sealing layer having a second sealing surface, the first sealing surface contacting the second sealing surface to define a seal such that one or both of the first and second scaling layers have one or more folds or bends incorporated therein, wherein at least one of the first and second sealing layers include: a thermoplastic polymer; and an organoclay dispersed within at least a portion of the thermoplastic polymer, wherein at least one of the first and second sealing layers has a seal initiation temperature from about 170 Deg. F to about 350 Deg. F, and at least one of the first and second sealing layers has a tensile modulus from about 500 to about 2000 MPa, the organoclay comprising platelets having an average separation of at least 20 angstroms and the sealing surface having a roughness average from about 1500 to about 5000 angstroms.
Patent NZ-589604-A (NZ)
Title: Conducting a stakeholder relationship analysis for an organisation by identifying driver latent variables based on a survey
Inventor: MCHALE RAYMOND
IPC: G06Q10/00
Filed: 2010-01-15
Abstract: 589604 Disclosed is a computer-implemented method for conducting a stakeholder relationship analysis for an organisation. A stakeholder model is selected from a plurality of models stored in memory such that the stakeholder model defines a plurality of latent variables (18) which include one or more experiential latent variables (12), one or more attitudinal latent variables (14) and one or more behavioural intention latent variables (20). Survey response data is recorded which indicative of a plurality of responses to a survey conducted in relation to the organisation. Based upon the stakeholder model and the survey response data, one or more driver latent variables are identified that impact upon the one or more behavioural intention latent variables (20). Using the stakeholder model and the one or more driver latent variables, impact data is generated that is indicative of a predicted impact upon the organisation due to one or more modifications to at least some of the one or more driver latent variables. A report is generated based on the impact data and is indicative of one or more proposed modifications to the organisation associated with the one or more modified driver latent variables, to thereby improve the stakeholder relationship for the organisation.
Patent NZ-591416-A (NZ)
Title: Antisense oligonucleotides directed against connective tissue growth factor and uses thereof
Inventor: DEAN NICHOLAS M
IPC: C12N15/113
Filed: 2009-08-25
Abstract: Disclosed are compounds which comprise a modified oligonucleotide consisting of at least 12 nucleosides which are present within the nucleobase sequence set forth in SEQ ID NO: 39 (gtttgacatggcacaatgtt).
Patent NZ-592819-A (NZ)
Title: Thyroid analyte detection and measurement
Inventor: DODDS W
IPC: G01N33/53
Filed: 2009-11-10
Abstract: Disclosed is a method of diagnosing thyroid disease in a canine wherein the method includes: a.) Obtaining a patient sample from a canine species; b.) Measuring thyroid analytes; c.) Applying a r-squared value of the ratio of T4 relative to Free T4 between 0.75 and 0.99, to establish a diagnostic specificity for canine thyroid disease such that thyroid disease can be diagnosed; and d.) Applying the measurement of the analytes and the application of the value as diagnosis of thyroid disease. Further disclosed is a method of diagnosing thyroid disease in a canine wherein the method includes a non-radioisotopic method of measuring thyroid analytes comprising using a panel of thyroid analytes and comprising: a.) Obtaining a patient sample of biological fluid from a canine species; b.) Incubating the sample with a non-radioisotopic label detectant; c.) Measuring T4 and Free T4 in the sample of the canine species using the non-radioisotopic label as the detectant; d.) Measuring T3 and Free T3 in the sample of the canine species using the non-radioisotopic label as the detectant; e.) Wherein the panel comprises exclusively measuring by the non-radioisotopic measurement of each of the analytes T3, Free T3, T4, and Free T4 collectively in the sample of biological fluid from the canine species such that thyroid disease can be diagnosed; and f.) Applying the measurement of the analytes as diagnosis of thyroid disease.
Patent NZ-599375-A (NZ)
Title: Microfibrous cellulose having a particle size distribution for structured surfactant compositions
Inventor: D AMBROGIO ROBERT
IPC: A61K8/73
Filed: 2010-11-04
Abstract: 599375 A Method of producing an aqueous composition comprising surfactant, water, and a suspending agent comprising microfibrous cellulose that is characterized by a particle size distribution of the micro fibrous cellulose that provides for increased structuring of the composition to suspend material where the method comprises processing an aqueous composition in a homogenizer measuring the particle size distribution by Focused Beam Reflectance Measurements and continuing the process until the desired particle size is achieved and then mixing a surfactant into the composition.
Patent NZ-600954-A (NZ)
Title: Isoindolinone inhibitors of phosphatidylinositol 3-kinase
Inventor: ARONOV ALEX
IPC: A61K31/352
Filed: 2010-12-21
Abstract: 600954 Disclosed herein is a compound of formula I, wherein the variables are defined in the specification, the use of said compound for inhibiting PI3K-gamma kinase activity, and the use of said compound for treating autoimmune disease or an inflammatory disease of the brain or spinal cord selected from multiple sclerosis, epilepsy, Parkinson's disease, Alzheimer's disease, Huntington's disease, or amyotrophic lateral sclerosis. Embodiments of the compound include the following: 2-(5-methoxy-3-pyridyl)-4-methyl-6-[1-(2,2,2-trifluoroethyl)pyrazol-4-yl]spiro[pyrrolo[3,4-b]pyridine-7,3'-tetrahydrofuran]-5-one, 2-(5,6-dimethoxy-3-pyridyl)-7-methyl-6-[1-(2,2,2-trifluoroethyl)pyrazol-4-yl]-7H-pyrrolo[3,4-b]pyridin-5-one, and 6-(1-(2-(1H-pyrazol-1-yl)ethyl)-1H-pyrazol-4-yl)-2-(5,6-dimethoxypyridin-3-y1)-6,7-dihydro-5H-pyrrolo[3,4-b]pyridin-5-one.
Patent NZ-601657-A (NZ)
Title: Combination therapies using melengestrol acetate and zilpaterol or its salts
Inventor: WRAY MARY IRENE
IPC: A61P43/00
Filed: 2008-12-04
Abstract: 601657 Disclosed is a method for improving feed utilization efficiency or increasing the rate of weight gain in a non-human animal, wherein the method comprises administering to the nonhuman animal an amount of zilpaterol or a salt thereof, an amount of melengestrol acetate, an amount of monensin or a salt thereof and an amount of tylosin or a salt thereof, wherein the amount of zilpaterol is about 1 to about 200 mg/animal/day, the amount of melengestrol acetate is about 0.01 to about 2 mg/animal/day, the amount of monensin is about 10 to about 500 mg/animal/day, and the amount of tylosin is about 10 to about 150 mg/animal/day. Also disclosed is a composition comprising zilpaterol, melengestrol acetate, monensin and tylosin and the use of zilpaterol, melengestrol acetate, monensin and tylosin in the manufacture of a medicament for improving feed utilization or increasing the rate of weight gain.
Patent NZ-601844-A (NZ)
Title: Constant-power supply for low impedance loads including a transformer with primary and secondary windings and a magnetic shunt for diverting magnetic flux associated with the windings
Inventor: WHITE CLIVE STUART
IPC: G05F1/10
Filed: 2011-02-16
Abstract: Disclosed is a constant-power supply apparatus (1) for low impedance loads. The apparatus (1) includes a transformer having a primary winding (3) and a secondary winding (4). Magnetic flux generated by a varying primary voltage applied to the primary winding (3) induces a varying secondary voltage on the secondary winding (4). The apparatus (1) also includes a torroidal transformer core (2) over which the primary winding (3) and secondary winding (4) are applied, wherein at least a portion of the secondary winding (4) is spatially separated from the primary winding (3). At least one magnetic shunt (5) is arranged to provide a diversion path for magnetic flux generated by the primary winding (3), which diverts magnetic flux from the secondary winding (4). A control coil is provided in association with the magnetic shunt (5), the control coil being adapted to dynamically modify the reluctance of the magnetic shunt (5) and thereby dynamically modifying the maximum output current capable of being delivered by the power supply (1).
Patent NZ-609900-A (NZ)
Title: Level wind assembly for a winch drum including a tensioning arm
Inventor: XYDIAS HARRY
IPC: B66D1/40
Filed: 2011-09-29
Abstract: A level wind arm (16) for a winch drum assembly, and a winch drum assembly incorporating such a level wind arm (16). The level wind arm (16) includes a cross member (36) adapted to bias against an outwardly extending portion of rope, the cross member (36) being concave so that more force is required for the rope spindle (42) associated with the cross member to “climb” the slope of the cross member, causing a momentary pause in motion of the spindle after it reaches the end of wind stroke. This momentary pause allows for rope (18) being wound onto the drum (20) to rise up the end wall of the drum (20) to create a new layer which is aligned and consistent with the layer below, without causing gaps in the rope (18) or other circumstances which could lead to the rope accumulating at any one point, or becoming tangled. The present invention also includes means of ensuring that tension is maintained in the rope (18), and that the rope (18) does not jump off the reel (20) and, for example, into the clutch mechanism. The means for retaining tension on the rope may be a tensioning arm (10) extending rearwardly (towards the reel) from the cross member (36) which acts directly on the rope wound onto the reel.
Patent NZ-706099-A (NZ)
Title: A method of processing a biomass material
Inventor: MEDOFF MARSHALL
IPC: G01T7/08
Filed: 2014-03-07
Abstract: Biomass feedstocks (e.g., plant biomass, animal biomass, and municipal waste biomass) are processed to produce useful products, such as fuels. For example, novel systems, methods and equipment for conveying and/or cooling treated biomass are described. The method comprises; providing a biomass to a first treatment cell equipped with a first electron beam device, irradiating the biomass with electron beams using the first electron beam device, and cooling and conveying the biomass material with a screw conveyor form the first treatment cell; conveying the biomass material to a second treatment cell equipped with a second electron beam device and irradiating the biomass material with an electron beam using the second electron beam device. Many potential lignocellulosic feedstocks are available today, including agricultural residues, woody biomass, municipal waste, oilseeds/cakes and seaweed, to name a few. At present, these materials are often under-utilized, being used, for example, as animal feed, biocompost materials, burned in a co-generation facility or even landfilled.
Patent NZ-709234-A (NZ)
Title: Orthotic device
Inventor: MATTHEWS MARTIN
IPC: A61F5/02
Filed: 2012-03-12
Abstract: An orthotic device is constructed as torso garment with reinforcement strap that goes over shoulder on one side and down under armpit and then diagonally across to hip region for correcting rotation of spine. The garment has an arm section on the one side but not on the other side.
Patent NZ-718062-A (NZ)
Title: Assembly for sequentially delivering substances, and associated methods
Inventor: BRADLEY CHRISTOPHER MICHEAL
IPC: A61M5/315
Filed: 2014-08-15
Abstract: It may be desirable to sequentially administer two substances from a single assembly, where the assembly is a combination of delivery devices capable of independently delivering the respective substances alone. Such a solution is found in an infusion assembly (100) having a stopper piston (200) capable of coupling a first infusion device (10) with a second infusion device (20). The stopper piston is configured to facilitate a two-stage seating arrangement in which a plunger is capable of being advanced to sequentially dispense a first and second substance from the infusion assembly. A nozzle of the second infusion device is moved from a first seating position to a second seating position to achieve dispense of the two substances in a sequential manner.